Abbott Laboratories (ABT) Current Deferred Tax Assets (2009 - 2014)

Abbott Laboratories has reported Current Deferred Tax Assets for 6 years, with the latest figure at $1.7 billion in Q4 2014.

• Quarterly Current Deferred Tax Assets fell 32.56% year-over-year to $1.7 billion in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $1.7 billion (down 32.56% YoY) and the FY2014 annual result came in at $1.7 billion, down 32.56% from the prior year.
• Current Deferred Tax Assets slipped to $1.7 billion in Q4 2014 per ABT's latest filing, from $2.5 billion in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $3.1 billion in Q4 2010 and troughed at $1.7 billion in Q4 2014.
• A 5-year average of $2.6 billion and a median of $2.7 billion in 2011 frame the typical range for Current Deferred Tax Assets.
• The sharpest annual moves came in 2010 and 2014: Current Deferred Tax Assets jumped 30.11% in 2010, then sank 32.56% in 2014.
• Over 5 years, Current Deferred Tax Assets stood at $3.1 billion in 2010, then fell by 12.19% to $2.7 billion in 2011, then increased by 10.55% to $3.0 billion in 2012, then fell by 15.34% to $2.5 billion in 2013, then tumbled by 32.56% to $1.7 billion in 2014.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $1.7 billion, $2.5 billion, and $3.0 billion for Q4 2014, Q4 2013, and Q4 2012 respectively.